Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

MESALAZINE PREFORMULATION AND SOLUBILITY STUDY

View through CrossRef
Objective: Aim of preformulation study is to develop the elegant, stable, effective and safe dosage form by assay solubility and stability study of MSL. Methods: Preformulation study was done to check the purity and stability of drug by different steps of preformulation study, first of this step involve identification of melting point by DSC, and by using UV spectrophotometry can be detection of lambda max and calibration curve in ethanol and phosphate buffer pH7.4. Drug was dissolved in different media to evaluate its solubility and stability in The study includes solubility, stability, and pH of drug in different oil (Almond oil, Grape oil, Sesame oil, Clove oil, Olive oil, Jojoba oil, and Labrafil oil), different surfactants (Cremophor, Tween 40, Tween 80, PEG 400, PEG600, PEG200, Labrasol), different co surfactants (Oleic acid, Imm 948, Vitamin E, frankincense oil, Labrafac oil, and Imwitor30 with and without different antioxidants (sodium thiosulfate, sodium metabisulfite, vitamin C, and Vitamin E. FTIR done to check purity and identity of drug and to evaluate MSL-solubilizing media interaction. Results: The results from the Preformulation studies show melting point and lambda max of mesalamine were found to be 285.5 °C and 330 nm respectively. MSL best condition of preparing in a solution in oil and acidic media at room temperature. The FTIR study of pure MSL confirms the purity of drug and FTIR show the interaction of drug with tween 40; in which FTIR of MSL-tween40 show chemical interaction. Conclusion: from solubility study of MSL in deferent media show different concentration of drug dissolve in mg/ml and stability of drug was affected by type of media mainly pH of media in which oil media show better stability.
Title: MESALAZINE PREFORMULATION AND SOLUBILITY STUDY
Description:
Objective: Aim of preformulation study is to develop the elegant, stable, effective and safe dosage form by assay solubility and stability study of MSL.
Methods: Preformulation study was done to check the purity and stability of drug by different steps of preformulation study, first of this step involve identification of melting point by DSC, and by using UV spectrophotometry can be detection of lambda max and calibration curve in ethanol and phosphate buffer pH7.
4.
Drug was dissolved in different media to evaluate its solubility and stability in The study includes solubility, stability, and pH of drug in different oil (Almond oil, Grape oil, Sesame oil, Clove oil, Olive oil, Jojoba oil, and Labrafil oil), different surfactants (Cremophor, Tween 40, Tween 80, PEG 400, PEG600, PEG200, Labrasol), different co surfactants (Oleic acid, Imm 948, Vitamin E, frankincense oil, Labrafac oil, and Imwitor30 with and without different antioxidants (sodium thiosulfate, sodium metabisulfite, vitamin C, and Vitamin E.
FTIR done to check purity and identity of drug and to evaluate MSL-solubilizing media interaction.
Results: The results from the Preformulation studies show melting point and lambda max of mesalamine were found to be 285.
5 °C and 330 nm respectively.
MSL best condition of preparing in a solution in oil and acidic media at room temperature.
The FTIR study of pure MSL confirms the purity of drug and FTIR show the interaction of drug with tween 40; in which FTIR of MSL-tween40 show chemical interaction.
Conclusion: from solubility study of MSL in deferent media show different concentration of drug dissolve in mg/ml and stability of drug was affected by type of media mainly pH of media in which oil media show better stability.

Related Results

Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis
Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis
Aim:To compare the efficacy and tolerability of olsalazine sodium with enteric‐coated mesalazine in inducing endoscopic remission in patients with mild to moderate active ulcerativ...
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Background: Ulcerative colitis is a chronic idiopathic inflammatory bowel disease (IBD) characterized by intestinal inflammation confined to the superficial mucosal layer. Mesalazi...
Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine
Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine
CONTEXT: Recent studies support the hypothesis that postinfectious irritable bowel syndrome and some irritable bowel syndrome patients display persistent signs of minor mucosal inf...
“Hepatotoxicity in inflammatory bowel disease: mesalazine, the forgotten drug”
“Hepatotoxicity in inflammatory bowel disease: mesalazine, the forgotten drug”
Introduction Mesalazine is a widely prescribed drug, used for the treatment of ulcerative colitis to both induce and maintain remissions in disease. Mesalazine therapy ...
Tests of renal function in patients with quiescent colitis: effects of drug treatment.
Tests of renal function in patients with quiescent colitis: effects of drug treatment.
Mesalazine has structural similarities to aspirin and phenacetin and is nephrotoxic when given intravenously in high doses to rats. A number of cases of nephrotoxicity has been rep...
P429 Mesalazine has no place in the treatment of Crohn’s disease. Really?
P429 Mesalazine has no place in the treatment of Crohn’s disease. Really?
Abstract Background According to international guidelines mesalazine may have no place in the treatment of Crohn’s disease (CD)....
CRP as a marker of inflammation: Mitigation of Ulcerative Colitis in rats by Mesalazine and Coenzyme Q10.
CRP as a marker of inflammation: Mitigation of Ulcerative Colitis in rats by Mesalazine and Coenzyme Q10.
Background: Ulcerative colitis is a global health issue with no definitive treatment options available. Mesalazine is one of the first-line therapies available, and Coenzyme Q10 is...
Surface Solid Dispersion Technique for Solubility Enhancement of Nifedipine
Surface Solid Dispersion Technique for Solubility Enhancement of Nifedipine
Introduction: Poor solubility is a common challenge in pharmaceuticals, hindering oral bioavailability. High throughput screening has led to an increase in poor...

Back to Top